- Home
- WOR vs HCM Comparison
WOR vs HCM Comparison
Compare WOR & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOR
- HCM
- Stock Information
- Founded
- WOR 1955
- HCM 2000
- Country
- WOR United States
- HCM Hong Kong
- Employees
- WOR N/A
- HCM N/A
- Industry
- WOR Aerospace
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- WOR Consumer Discretionary
- HCM Health Care
- Exchange
- WOR Nasdaq
- HCM Nasdaq
- Market Cap
- WOR 2.8B
- HCM 2.6B
- IPO Year
- WOR N/A
- HCM N/A
- Fundamental
- Price
- WOR $55.05
- HCM $15.25
- Analyst Decision
- WOR Buy
- HCM Sell
- Analyst Count
- WOR 3
- HCM 1
- Target Price
- WOR $61.00
- HCM $13.75
- AVG Volume (30 Days)
- WOR 162.3K
- HCM 32.8K
- Earning Date
- WOR 12-16-2025
- HCM 08-07-2025
- Dividend Yield
- WOR 1.39%
- HCM N/A
- EPS Growth
- WOR 179.34
- HCM N/A
- EPS
- WOR 2.14
- HCM 0.53
- Revenue
- WOR $1,200,161,000.00
- HCM $602,197,000.00
- Revenue This Year
- WOR $14.93
- HCM N/A
- Revenue Next Year
- WOR $4.45
- HCM $15.49
- P/E Ratio
- WOR $25.62
- HCM $5.55
- Revenue Growth
- WOR 0.76
- HCM N/A
- 52 Week Low
- WOR $37.88
- HCM $11.51
- 52 Week High
- WOR $70.91
- HCM $19.50
- Technical
- Relative Strength Index (RSI)
- WOR 42.75
- HCM 50.16
- Support Level
- WOR $54.19
- HCM $14.40
- Resistance Level
- WOR $55.78
- HCM $15.77
- Average True Range (ATR)
- WOR 1.22
- HCM 0.33
- MACD
- WOR 0.01
- HCM 0.07
- Stochastic Oscillator
- WOR 18.32
- HCM 66.67
About WOR Worthington Enterprises Inc.
Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.